109 related articles for article (PubMed ID: 32087970)
1. An RNA-binding-protein, NONO governs energy metabolism by regulating NAMPT in lung cancer.
Kim SJ; Ju JS; Park SS; Suh YA; Yoo HJ; Choi EK; Seong-Yun Jeong ; Shin Y; Park YY
Biochem Biophys Res Commun; 2020 Jul; 528(2):376-382. PubMed ID: 32087970
[TBL] [Abstract][Full Text] [Related]
2. RNA-binding protein NONO contributes to cancer cell growth and confers drug resistance as a theranostic target in TNBC.
Kim SJ; Ju JS; Kang MH; Eun JW; Kim YH; Raninga PV; Khanna KK; Győrffy B; Pack CG; Han HD; Lee HJ; Gong G; Shin Y; Mills GB; Eyun SI; Park YY
Theranostics; 2020; 10(18):7974-7992. PubMed ID: 32724453
[TBL] [Abstract][Full Text] [Related]
3. The transcribed ultraconserved element uc.51 promotes the proliferation and metastasis of breast cancer by stabilizing NONO.
Shi X; Huang X; Chen R; Li Y; Xu Y; Zhang W; Zhu Q; Zha X; Wang J
Clin Exp Metastasis; 2021 Dec; 38(6):551-571. PubMed ID: 34714466
[TBL] [Abstract][Full Text] [Related]
4. Nicotinamide phosphoribosyl transferase regulates cell growth via the Sirt1/P53 signaling pathway and is a prognosis marker in colorectal cancer.
Pan JH; Zhou H; Zhu SB; Huang JL; Zhao XX; Ding H; Qin L; Pan YL
J Cell Physiol; 2019 Apr; 234(4):4385-4395. PubMed ID: 30191976
[TBL] [Abstract][Full Text] [Related]
5. Expression of nicotinamide phosphoribosyltransferase-influenced genes predicts recurrence-free survival in lung and breast cancers.
Zhou T; Wang T; Garcia JG
Sci Rep; 2014 Aug; 4():6107. PubMed ID: 25146220
[TBL] [Abstract][Full Text] [Related]
6.
Lucena-Cacace A; Otero-Albiol D; Jiménez-García MP; Muñoz-Galvan S; Carnero A
Clin Cancer Res; 2018 Mar; 24(5):1202-1215. PubMed ID: 29203587
[No Abstract] [Full Text] [Related]
7. Nicotinamide phosphoribosyltransferase: a potent therapeutic target in non-small cell lung cancer with epidermal growth factor receptor-gene mutation.
Okumura S; Sasaki T; Minami Y; Ohsaki Y
J Thorac Oncol; 2012 Jan; 7(1):49-56. PubMed ID: 22089115
[TBL] [Abstract][Full Text] [Related]
8. RNA-binding protein p54
Shen M; Zhang R; Jia W; Zhu Z; Zhao L; Huang G; Liu J
Cell Death Dis; 2022 Jan; 13(1):42. PubMed ID: 35013116
[TBL] [Abstract][Full Text] [Related]
9. NAMPT: A potential prognostic and therapeutic biomarker in patients with glioblastoma.
Guo Q; Han N; Shi L; Yang L; Zhang X; Zhou Y; Yu S; Zhang M
Oncol Rep; 2019 Sep; 42(3):963-972. PubMed ID: 31322259
[TBL] [Abstract][Full Text] [Related]
10. NONO promotes gallbladder cancer cell proliferation by enhancing oncogenic RNA splicing of DLG1 through interaction with IGF2BP3/RBM14.
Yang ZY; Zhao C; Liu SL; Pan LJ; Zhu YD; Zhao JW; Wang HK; Ye YY; Qiang J; Shi LQ; Mei JW; Xie Y; Gong W; Shu YJ; Dong P; Xiang SS
Cancer Lett; 2024 Apr; 587():216703. PubMed ID: 38341127
[TBL] [Abstract][Full Text] [Related]
11. FOXO1 functions in the regulation of nicotinamide phosphoribosyltransferase (Nampt) expression.
Jeong B; Park JW; Kim JG; Lee BJ
Biochem Biophys Res Commun; 2019 Apr; 511(2):398-403. PubMed ID: 30799084
[TBL] [Abstract][Full Text] [Related]
12. RNA-binding protein NONO promotes breast cancer proliferation by post-transcriptional regulation of SKP2 and E2F8.
Iino K; Mitobe Y; Ikeda K; Takayama KI; Suzuki T; Kawabata H; Suzuki Y; Horie-Inoue K; Inoue S
Cancer Sci; 2020 Jan; 111(1):148-159. PubMed ID: 31733123
[TBL] [Abstract][Full Text] [Related]
13. Effect of Phosphoribosyltransferase Down-regulation on Malignant Glioma Cell Characteristics.
Kamada M; Ikeda K; Manome Y
Anticancer Res; 2020 Sep; 40(9):4895-4905. PubMed ID: 32878777
[TBL] [Abstract][Full Text] [Related]
14. NONO Inhibits Lymphatic Metastasis of Bladder Cancer via Alternative Splicing of SETMAR.
Xie R; Chen X; Cheng L; Huang M; Zhou Q; Zhang J; Chen Y; Peng S; Chen Z; Dong W; Huang J; Lin T
Mol Ther; 2021 Jan; 29(1):291-307. PubMed ID: 32950106
[TBL] [Abstract][Full Text] [Related]
15. An NAD+-dependent transcriptional program governs self-renewal and radiation resistance in glioblastoma.
Gujar AD; Le S; Mao DD; Dadey DY; Turski A; Sasaki Y; Aum D; Luo J; Dahiya S; Yuan L; Rich KM; Milbrandt J; Hallahan DE; Yano H; Tran DD; Kim AH
Proc Natl Acad Sci U S A; 2016 Dec; 113(51):E8247-E8256. PubMed ID: 27930300
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of NAMPT expression by miR-182 is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation.
Chen XY; Zhang HS; Wu TC; Sang WW; Ruan Z
Int J Biochem Cell Biol; 2013 Feb; 45(2):292-8. PubMed ID: 23153509
[TBL] [Abstract][Full Text] [Related]
17. Nicotinic Acid Phosphoribosyltransferase Regulates Cancer Cell Metabolism, Susceptibility to NAMPT Inhibitors, and DNA Repair.
Piacente F; Caffa I; Ravera S; Sociali G; Passalacqua M; Vellone VG; Becherini P; Reverberi D; Monacelli F; Ballestrero A; Odetti P; Cagnetta A; Cea M; Nahimana A; Duchosal M; Bruzzone S; Nencioni A
Cancer Res; 2017 Jul; 77(14):3857-3869. PubMed ID: 28507103
[TBL] [Abstract][Full Text] [Related]
18. Small interfering RNA-mediated silencing of nicotinamide phosphoribosyltransferase (NAMPT) and lysosomal trafficking regulator (LYST) induce growth inhibition and apoptosis in human multiple myeloma cells: A preliminary study.
Bong IP; Ng CC; Fakiruddin SK; Lim MN; Zakaria Z
Bosn J Basic Med Sci; 2016 Nov; 16(4):268-275. PubMed ID: 27754828
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathway.
Wang LF; Wang XN; Huang CC; Hu L; Xiao YF; Guan XH; Qian YS; Deng KY; Xin HB
Lipids Health Dis; 2017 Apr; 16(1):82. PubMed ID: 28449683
[TBL] [Abstract][Full Text] [Related]
20. Nicotinamide phosphoribosyltransferase (Nampt) may serve as the marker for osteoblast differentiation of bone marrow-derived mesenchymal stem cells.
He X; He J; Shi Y; Pi C; Yang Y; Sun Y; Ma C; Lin L; Zhang L; Li Y; Li Y
Exp Cell Res; 2017 Mar; 352(1):45-52. PubMed ID: 28159473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
